Clinical efficacy and mechanisms of Fuzheng Quxie Method combined with reduced-dose demethylation regimen in the treatment of acute myeloid leukemia in the elderly
|更新时间:2026-06-02
|
Clinical efficacy and mechanisms of Fuzheng Quxie Method combined with reduced-dose demethylation regimen in the treatment of acute myeloid leukemia in the elderly
Beijing Journal of Traditional Chinese MedicineVol. 45, Issue 3, Pages: 310-316(2026)
REN Zirui,WANG Shengyong,LU Hao,et al.Clinical efficacy and mechanisms of Fuzheng Quxie Method combined with reduced-dose demethylation regimen in the treatment of acute myeloid leukemia in the elderly[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(03):310-316.
REN Zirui,WANG Shengyong,LU Hao,et al.Clinical efficacy and mechanisms of Fuzheng Quxie Method combined with reduced-dose demethylation regimen in the treatment of acute myeloid leukemia in the elderly[J]. Beijing Journal of Traditional Chinese Medicine,2026,45(03):310-316.DOI: 10.16025/j.1674-1307.2026.03.005.
Clinical efficacy and mechanisms of Fuzheng Quxie Method combined with reduced-dose demethylation regimen in the treatment of acute myeloid leukemia in the elderly
) in combination with a reduced-dose demethylation regimen for the treatment of elderly patients with acute myeloid leukemia (AML), and to investigate its effects on activating transcription factor 4 (ATF4) and interleukin-6 (IL-6), thereby preliminarily exploring its mechanisms of action in elderly AML.
Methods
2
Sixty elderly patients with non-M3 AML who met the inclusion criteria and were treated in the Department of Hematology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, from August 2021 to December 2022 were enrolled. Patients were randomly divided into two groups, with 30 cases in the observation group and 30 cases in the control group. The observation group was treated with the
Fuzheng Quxie Method
(
Dingqing Tablets
combined with
Fuzheng Quxie
compound formula) plus a reduced-dose demethylation regimen, while the control group received standard demethylation therapy. One treatment course was 4 weeks, and after 3 courses, clinical data were collected for efficacy evaluation and statistical analysis. Outcomes included traditional Chinese medicine (TCM) syndrome efficacy, Western medical efficacy, routine blood parameters, p
roportion of blast cells, ATF4 expression, and IL-6 levels.
Results
2
The observation group showed superior total effective rate and TCM syndrome efficacy compared with the control group. It also demonstrated better effects in inhibiting abnormal leukocyte proliferation and improving platelet and hemoglobin levels. ATF4 expression in the observation group increased after treatment compared with that before treatment, while no significant change was observed in the control group. After treatment, IL-6 levels decreased in both groups, with a more significant reduction observed in the observation group.
Conclusion
2
The
Fuzheng Quxie Method
combined with a reduced-dose demethylation regimen shows significant advantages in both clinical efficacy and TCM syndrome improvement in elderly AML patients. It can effectively inhibit abnormal leukocyte proliferation, increase platelet and hemoglobin levels, and also demonstrates advantages in regulating gene expression and suppressing inflammatory responses.
关键词
Keywords
references
SHIMONY S , STAHL M , STONE RM . Acute myeloid leukemia:2023 update on diagnosis,risk‐stratification,and management [J ] . Am J Hematol , 2023 , 98 ( 3 ): 502 - 526 .
DöHNER H , WEI AH , LöWENBERG B . Towards precision medicine for AML [J ] . Nat Rev Clin Oncol , 2021 , 18 ( 9 ): 577 - 590 .
PALMIERI R , PATERNO G , DE BELLIS E , et al . Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of Fitness [J ] . Cancers (Basel) , 2020 , 12 ( 1 ): 120 .
ALFAYEZ M , KANTARJIAN H , KADIA T , et al . Emerging drug profile:CPX-351(vyxeos) in AML [J ] . Leuk Lymphoma , 2020 , 61 ( 2 ): 288 - 297 .
ZHENG D , ZHOU Y , LIU Y , et al . Molecular Mechanism Investigation on Monomer Kaempferol of the Traditional Medicine Dingqing Tablet in Promoting Apoptosis of Acute Myeloid Leukemia HL-60 Cells [J ] . Evid Based Complement Alternat Med , 2022 , 2022 : 8383315 .
BAO J , ZHAO X , LU J , et al . Platelet transcriptome profiles provide potential therapeutic targets for elderly acute myelocytic leukemia patients [J ] . J Transl Med , 2021 , 19 ( 1 ): 388 .
ZHAO Z , DONG Q , LIU X , et al . Dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest [J ] . Genomics , 2020 , 112 ( 2 ): 1309 - 1317 .
SRIVASTAVA RK , LI C , AHMAD A , et al . ATF4 regulates arsenic trioxide-mediated NADPH oxidase, ER-mitochondrial crosstalk and apoptosis [J ] . Arch Biochem Biophys , 2016 , 609 : 39 - 50 .
ZHANG Y , GUO H , ZHANG Z , et al . IL-6 promotes chemoresistance via upregulating CD36 mediated fatty acids uptake in acute myeloid leukemia [J ] . Exp Cell Res , 2022 , 415 ( 1 ): 113112 .
BRENJIAN S , MOINI A , YAMINI N , et al . Resveratrol treatment in patients with polycystic ovary syndrome decreased pro-inflammatory and endoplasmic reticulum stress markers [J ] . Am J Reprod Immunol , 2020 , 83 ( 1 ): e13186 .
Clinical efficacy of acupuncture-medicine combination in treatment of 74 patients with sudden sensorineural hearing loss complicated by type 2 diabetes mellitus
Efficacy of combined regimen of induction chemotherapy plus Yiyiren Oil Injection on elderly AML(M3 excluded)- an observation of 32 cases
Clinical effect of Bushen Tongluo Recipe on rheumatoid arthritis of liver and kidney yin deficiency type and its influence on related cytokines
Mechanism of Zhebei Huangqin Decoction for inhibiting proliferation of kasumi-1 tumor-bearing mice by regulating wip1-p53
Differentiation and treatment of acne based on the "sweat pore-nutrient-defense system" theory
Related Author
YAN Zhanfeng
ZHANG Ying
XIE Dandan
ZHANG Lingjing
GONG Zheng
YUAN Jingjing
PENG Yanru
ZHANG Haiyang
Related Institution
Department of Otolaryngology, Dongzhimen Hospital of Beijing University of Chinese Medicine
Department of Hematology and Oncology,Dongzhimen Hospital,Beijing University of Chinese Medicine
Department of Clinical Laboratory,Affiliated Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine
Department of Hematology Oncology, Dongzhimen Hospital,Beijing University of Chinese Medicine